| Application no. and date | 14793463.2 (espacenet) (Federated) (European Patent Register), 20141017 | | Patent/reg. no. and date | DK/EP 3057983, 20191113 | | Publication date | 20160824 | | Priority no. and date | US 201361892250 P, 20131017 | | EP pub. no. and date |
EP 3057983 20160824 | | Effective date | | | Applicant/owner | ZEALAND PHARMA A/S, Sydmarken 11, 2860 Søborg, DK,
Boehringer Ingelheim International GmbH, Binger Strasse 173
55216 Ingelheim am Rhein, DE | | Applicant ref. no. | V46893DK00 | | Inventor | TOLBORG, Jakob Lind, Zealand Pharma A/S
Smedeland 36, 2600 Glostrup, DK,
RIBER, Ditte, Zealand Pharma A/S
Smedeland 36, 2600 Glostrup, DK,
HAMPRECHT, Dieter Wolfgang, Boehringer Ingelheim GmbH
Binger Strasse 173
55216 Ingelheim am Rhein, DE | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | C07K 14/605 (2006.01) | | Title | Glucagon-analoger | | Int. application no. | EP2014072294 | | Int. publication no. | WO2015055802 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
